Columbia Basin Hematology & Oncology

Kennewick, Washington 99336

0 studies enrolling now · 5 studies all time

What they study most

Breakthrough Cancer Pain, Breast Cancer, Breast Cancer, Estrogen Receptor-Positive, ER+ Breast Cancer, Early-Stage Breast Carcinoma, Estrogen Receptor-Positive Breast Cancer, Hormone Receptor Positive Tumor, Metastatic Breast Cancer, Non Small Cell Lung Cancer (NSCLC), Quality of Life, Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Studies at this site

• Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast Cancer — Completed
• A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer — Completed
• Study of PX-866 and Docetaxel in Solid Tumors — Completed
• Ixabepilone + Carboplatin Metastatic Breast Cancer — Completed
• Observational Registry Study of Quality of Life When Treating BTcP With Abstral — Completed